Alexandria Real Estate Equities, Inc. ARE | NYSE

$99.17 $1.88 | 1.93%

After Hours
$100.42 $1.25 | 1.26%

Next Earnings: Jan 27, 2025

Company Overview:

Market Cap: $17.33B
PE Ratio: 60.47
52-Week Range: $97.21 - $131.44
Dividend Yield (FWD): 5.32% ($5.28)

10 Year Performance Metrics:

Total Return (with DRIP): 48.85% (4.06% / yr)
Total Return (no DRIP): 53.05% (4.35% / yr)
Share Price: 10.31%
Dividend Increase: 75.68%
ARE 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

ARE Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
ARE Dividend CAGR:1Y: 3.94%2Y: 4.45%5Y: 5.09%10Y: 5.96%
Share Price
ARE Price CAGR:1Y: -21.59%2Y: -17.26%5Y: -9.04%10Y: 1.15%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

ARE Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - ARE
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - ARE
14-Day FREE Trial Get Full Access Now!

ARE Earnings, Revenue, Cash & Debt, Shares Outstaning:

ARE - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
ARE - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ARE - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ARE - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
ARE - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
ARE - Cash & Debt
14-Day FREE Trial Get Full Access Now!
ARE - Revenue
14-Day FREE Trial Get Full Access Now!
ARE Revenue CAGR:1Y: 8.68%2Y: 8.43%5Y: 14.72%10Y: 15.37%
ARE - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
ARE EPS CAGR:1Y: 638.46%2Y: -32.87%5Y: 33.78%10Y: 9.43%
ARE - Net Income
14-Day FREE Trial Get Full Access Now!
ARE Net Income CAGR:1Y: 578.54%2Y: -30.88%5Y: 40.57%10Y: 16.88%
ARE - EBITDA
14-Day FREE Trial Get Full Access Now!
ARE EBITDA CAGR:1Y: -25.99%2Y: 12.47%5Y: 15.73%10Y: 16.16%
ARE - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
ARE Free Cash Flow CAGR:1Y: 311.06%2Y: 14.67%5Y: 21.69%10Y: 38.17%
ARE - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
ARE Free Cash Flow / Share CAGR:1Y: 309.62%2Y: 11.12%5Y: 19.49%10Y: 27.85%
ARE - Gross Profit
14-Day FREE Trial Get Full Access Now!
ARE Gross Profit CAGR:1Y: -47.71%2Y: -26.40%5Y: -1.94%10Y: 6.84%
ARE - Expenses
14-Day FREE Trial Get Full Access Now!
ARE Expenses CAGR:1Y: -100.00%2Y: N/A5Y: -100.00%10Y: -100.00%
ARE - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
ARE Shares Outstanding CAGR:1Y: 0.68%2Y: 3.20%5Y: 8.94%10Y: 9.23%
ARE - Share Buybacks
14-Day FREE Trial Get Full Access Now!
ARE Share Buybacks CAGR:1Y: 251.69%2Y: 23.06%5Y: 5.10%10Y: N/A
ARE - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
ARE Stock-Based Comp CAGR:1Y: -4.68%2Y: -6.57%5Y: 7.26%10Y: 17.60%
ARE - Dividends
14-Day FREE Trial Get Full Access Now!
ARE Dividend CAGR:1Y: 3.94%2Y: 4.45%5Y: 5.09%10Y: 5.96%
ARE - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
ARE Revenue CAGR:1Y: 8.68%2Y: 8.43%5Y: 14.72%10Y: 15.37%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ARE - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ARE Actual Revenue CAGR:1Y: 8.68%2Y: 8.43%5Y: 14.72%10Y: 15.37%
ARE - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ARE Actual EPS CAGR:1Y: 638.46%2Y: -32.87%5Y: 33.78%10Y: 9.43%
ARE - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ARE Actual Net Income CAGR:1Y: 578.54%2Y: -30.88%5Y: 40.57%10Y: 16.88%
ARE - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ARE Actual EBITDA CAGR:1Y: -25.99%2Y: 12.47%5Y: 15.73%10Y: 16.16%

Ratios, Profit Margins & Return on Capital:

ARE - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
ARE Net Profit Margin CAGR:1Y: 524.41%2Y: -36.25%5Y: 30.30%10Y: 1.31%
ARE - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
ARE Gross Profit Margin CAGR:1Y: -51.89%2Y: -32.12%5Y: -14.52%10Y: -7.40%
ARE - Price to Earnings
14-Day FREE Trial Get Full Access Now!
ARE - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
ARE - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
ARE - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

ARE Dividends Info:

Annual Dividend: $5.28
Forward Yield: 5.32%
Ex-Dividend Date: 2024-12-31
Lifetime Dividens / Share: $80.51

ARE Dividend History: Dates, Payments & Yield list

Below is a schedule of all ARE dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
12/31/202401/15/2025$1.3205.23%5.32%$99.17
09/30/202410/15/2024$1.3004.33%4.38%$118.75
06/28/202407/15/2024$1.3004.34%4.45%$116.97
06/27/202407/15/2024$1.3004.36%4.47%$116.39
03/27/202404/15/2024$1.2703.93%3.98%$127.68
12/28/202301/12/2024$1.2703.85%3.94%$128.90
09/28/202310/13/2023$1.2404.93%4.99%$99.31
06/29/202307/14/2023$1.2404.27%4.38%$113.37
03/30/202304/14/2023$1.2103.86%3.9%$123.98
12/29/202201/13/2023$1.2103.25%3.33%$145.20
09/29/202210/14/2022$1.1803.37%3.41%$138.44
06/29/202207/15/2022$1.1803.18%3.27%$144.54
03/30/202204/15/2022$1.1502.25%2.28%$202.08
12/30/202101/14/2022$1.1502.01%2.06%$223.16
09/29/202110/15/2021$1.1202.29%2.32%$192.84
06/29/202107/15/2021$1.1202.38%2.45%$183.02
03/30/202104/15/2021$1.0902.59%2.62%$166.27
12/30/202001/15/2021$1.0902.42%2.49%$175.09
09/29/202010/15/2020$1.0602.61%2.65%$159.93
06/29/202007/15/2020$1.0602.55%2.62%$161.63
03/30/202004/15/2020$1.0302.81%2.85%$144.65
12/30/201901/15/2020$1.0302.51%2.58%$159.67
09/27/201910/15/2019$1.0002.57%2.61%$153.11
06/27/201907/15/2019$1.0002.76%2.86%$140.06
03/28/201904/15/2019$0.9702.65%2.71%$143.23
12/28/201801/15/2019$0.9703.27%3.41%$113.94
09/27/201810/15/2018$0.9302.98%3.03%$122.73
06/28/201807/16/2018$0.9302.84%2.94%$126.34
03/28/201804/16/2018$0.9002.85%2.91%$123.56
12/28/201701/15/2018$0.9002.64%2.76%$130.67
09/28/201710/16/2017$0.8602.88%2.93%$117.48
06/28/201707/17/2017$0.8602.75%2.85%$120.53
03/29/201704/17/2017$0.8302.97%3.02%$109.82
12/28/201601/17/2017$0.8302.98%3.06%$108.54
09/28/201610/17/2016$0.8002.81%2.84%$112.80
06/28/201607/15/2016$0.8003.14%3.2%$99.86
03/29/201604/15/2016$0.8003.42%3.52%$90.88
12/29/201501/15/2016$0.7703.32%3.35%$92.00
09/28/201510/15/2015$0.7703.53%3.6%$85.45
06/26/201507/15/2015$0.7703.35%3.47%$88.67
03/27/201504/15/2015$0.7403%3.04%$97.40
12/29/201401/15/2015$0.7403.21%3.3%$89.78
09/26/201410/15/2014$0.7203.79%3.87%$74.34
06/26/201407/15/2014$0.7203.64%3.77%$76.32
03/27/201404/15/2014$0.7003.8%3.93%$71.28
12/27/201301/15/2014$0.6804.11%4.28%$63.57
09/26/201310/15/2013$0.6803.84%4.19%$64.89
06/26/201307/15/2013$0.6503.66%4.07%$63.87
03/26/201304/15/2013$0.6003.08%3.36%$71.49
12/27/201201/15/2013$0.5603.06%3.27%$68.40
09/26/201210/15/2012$0.5302.76%2.9%$73.17
06/27/201207/16/2012$0.5102.82%2.94%$69.44
03/28/201204/13/2012$0.4902.62%2.71%$72.44
12/28/201101/17/2012$0.4902.72%2.87%$68.33
09/28/201110/17/2011$0.4703.01%3.11%$60.47
06/28/201107/15/2011$0.4502.22%2.35%$76.75
03/29/201104/15/2011$0.4502.09%2.36%$76.42
12/29/201001/17/2011$0.4502.06%2.47%$72.96
09/29/201010/15/2010$0.3502.01%2.01%$69.62
06/29/201007/15/2010$0.3502.2%2.2%$63.78
03/30/201004/15/2010$0.3502.05%2.05%$68.17
12/29/200901/15/2010$0.3502.81%2.13%$65.81
09/29/200910/15/2009$0.3504.16%2.53%$55.32
06/29/200907/15/2009$0.3507.71%3.92%$35.68
03/30/200904/15/2009$0.8009.41%9.41%$34.02
12/30/200801/15/2009$0.8005.44%5.47%$58.48
09/26/200810/15/2008$0.8002.8%2.83%$113.00
06/27/200807/15/2008$0.8003.18%3.26%$98.11
03/28/200804/15/2008$0.7803.35%3.39%$91.96
12/28/200701/15/2008$0.7803.02%3.1%$100.72
09/27/200710/15/2007$0.7603.12%3.17%$96.04
06/28/200707/13/2007$0.7603.04%3.12%$97.49
03/29/200704/13/2007$0.7402.91%2.97%$99.59
12/28/200601/15/2007$0.7402.85%2.95%$100.39
09/28/200610/13/2006$0.7202.99%3.06%$94.24
06/29/200607/14/2006$0.7003.14%3.16%$88.49
03/30/200604/14/2006$0.7002.9%2.94%$95.25
12/28/200501/13/2006$0.7003.36%3.46%$81.00
09/29/200510/14/2005$0.6803.24%3.29%$82.65
06/29/200507/15/2005$0.6803.6%3.71%$73.35
03/30/200504/15/2005$0.6604.01%4.1%$64.35
12/30/200401/14/2005$0.6603.4%3.56%$74.19
09/29/200410/15/2004$0.6403.76%3.95%$64.85
06/30/200407/15/2004$0.6204.16%4.37%$56.78
03/31/200404/15/2004$0.6003.6%3.81%$63.00
12/30/200301/15/2004$0.5803.74%3.94%$58.90
09/29/200310/15/2003$0.5604.42%4.67%$48.00
07/01/200307/14/2003$0.5304.57%4.7%$45.10
03/28/200304/11/2003$0.5304.86%5.07%$41.81
12/31/200201/13/2003$0.5004.69%4.69%$42.60
10/02/200210/15/2002$0.5004.72%4.82%$41.50
07/02/200207/15/2002$0.5004.05%4.22%$47.41
04/03/200204/15/2002$0.5004.27%4.54%$44.03
01/02/200201/15/2002$0.4604.5%4.5%$40.89
10/03/200110/15/2001$0.4604.57%4.65%$39.60
07/03/200107/16/2001$0.4604.58%4.74%$38.83
04/04/200104/16/2001$0.4604.68%4.92%$37.40
01/02/200101/15/2001$0.4304.7%4.7%$36.56
10/03/200010/16/2000$0.4305.05%5.05%$34.06
06/30/200007/14/2000$0.4305.01%5.01%$34.30
03/31/200004/14/2000$0.4305.73%5.73%$30.00
12/31/199901/14/2000$0.4305.31%5.41%$31.81
10/01/199910/15/1999$0.4305.6%5.8%$29.63
06/30/199907/15/1999$0.4305.22%5.5%$31.25
03/30/199904/12/1999$0.4006.34%6.34%$25.25
12/31/199801/15/1999$0.4005.17%5.17%$30.94
10/02/199810/16/1998$0.4004.27%5.69%$28.13
07/02/199807/17/1998$0.4002.69%5.38%$29.75
04/03/199804/17/1998$0.4001.28%5.13%$31.19

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for ARE

Based on past 10-year performance, here are ARE growth metrics:

Share price CAGR of +0.99%
Dividend CAGR of +5.96%
Using ARE CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

ARE
Current Price$99.17
Start Shares100.84
Start Value$10,000
 
After 10 years:
Final Share Count193.49
Dividends Payment$2.32
Annual Dividends$1,795
Yield on cost17.95%
Share Price$108.33
Total Dividends$9,694
Final Value$20,960

Estimated Future Value + Dividends - ARE

NOTE: Above numbers are our estimate based on ARE's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Alexandria Real Estate Equities, Inc. (ARE) had its IPO on 1997-05-28, and is trader on NYSE stock exchange.

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust ("REIT"), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet ("SF"). The asset base in North America includes 31.9 million RSF of operating properties and 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, technology, and agtech campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, technology, and agtech companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

ARE website: https://www.are.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial